Drug Database
Back to search

Norway· NO-ID_A92E942C-E844-46AE-97B1-CBDEABD4D7BB

Daxas

A roflumilast product containing roflumilast, registered in Norway by AstraZeneca. The same ATC class is registered in 12 of our 19 countries.

ATC R03DX07

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedDaxasATCR03DX07REGISTER NO.NO-ID_A92E942C-E844-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about roflumilastAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Roflumilast is registered in 12 of 19 countries.

Countries holding a registration under ATC R03DX07 (roflumilast), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose
Search roflumilast products by name

Roflumilast · ATC R03DX07

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of roflumilast costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Roflumilast · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.02
  • IT Italy$2.50
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Roflumilast
Manufacturer
AstraZeneca
Country
Norway (NO)
ATC code
R03DX07
ATC class
Roflumilast
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_A92E942C-E844-46AE-97B1-CBDEABD4D7BB
  • no_varenummer
    362787
    28
  • gtin
    4150134753191

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

352 interactions on record for roflumilast.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check roflumilast against other medicinesHow interaction checks work

Roflumilast · interactions on record

352 records

  • 2 severe
  • 347 moderate
  • 3 minor

Most severe, free to view

  • CladribineL01BB04severe
  • CimetidineA02BA01moderate
  • Obeticholic acidA05AA04moderate
  • PrednisoloneA07EA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Roflumilast in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All roflumilast products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Rofluma, Roflumilast Accord
  • Cyprus · Damirast
  • Czechia · Rumixafen
  • Germany · Roflum Hexal, Roflumila Puren
  • Denmark · Firekol
  • Spain · Roflumilast Aurovitas
  • Finland · Firekol
  • United Kingdom (Northern Ireland) · Roflumilast Milpharm, Roflumilast Torrent Pharma (Uk)
  • Greece · Damirast
  • Iceland · Daxas
  • Liechtenstein · Daxas
  • Portugal · Roflumilaste Generis
  • Sweden · Firekol, Roflumilast Accord
  • Slovakia · Rumixafen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9b244aab-58da-43f3-b8fd-98ab6d7685d2
GET /v1/drugs/9b244aab-58da-43f3-b8fd-98ab6d7685d2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Roflumilast",
  "merkevare_id": "ID_A92E942C-E844-46AE-97B1-CBDEABD4D7BB",
  "name_form_strength": "Daxas tab 250 mikrog",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about roflumilast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console